SAFETY AND ANTIBODY RESPONSE TO TWO-DOSE SARS-COV-2 MESSENGER RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA

Abstract Background Patients pet calming peanut butter with multiple myeloma (MM) were excluded from the original SARS-CoV-2 mRNA vaccine trials, which may influence vaccine hesitancy in this population.We prospectively characterized the safety and immunogenicity of two-dose SARS-CoV-2 mRNA vaccination in 44 patients with MM, who underwent vaccinat

s2720 The changing global climate brings a gradual yet constant and adverse shift in crop production.Grain crop plants, particularly cereals and legumes, respond varyingly to adverse climate, including reduction in grain yield and changes to their nutrient densities.An understanding of specific changes to crop systems under differing climatic condi